BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28755520)

  • 1. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.
    Chhabra Y; Yong HXL; Fane ME; Soogrim A; Lim W; Mahiuddin DN; Kim RSQ; Ashcroft M; Beatson SA; Ainger SA; Smit DJ; Jagirdar K; Walker GJ; Sturm RA; Smith AG
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):51-63. PubMed ID: 28755520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
    Visser M; Palstra RJ; Kayser M
    Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
    Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
    Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF4 rs12203592 functional variant and melanoma survival.
    Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
    Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.
    Mo X; Zhang H; Preston S; Martin K; Zhou B; Vadalia N; Gamero AM; Soboloff J; Tempera I; Zaidi MR
    Cancer Res; 2018 Jan; 78(2):436-450. PubMed ID: 29150430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.
    Praetorius C; Grill C; Stacey SN; Metcalf AM; Gorkin DU; Robinson KC; Van Otterloo E; Kim RS; Bergsteinsdottir K; Ogmundsdottir MH; Magnusdottir E; Mishra PJ; Davis SR; Guo T; Zaidi MR; Helgason AS; Sigurdsson MI; Meltzer PS; Merlino G; Petit V; Larue L; Loftus SK; Adams DR; Sobhiafshar U; Emre NC; Pavan WJ; Cornell R; Smith AG; McCallion AS; Fisher DE; Stefansson K; Sturm RA; Steingrimsson E
    Cell; 2013 Nov; 155(5):1022-33. PubMed ID: 24267888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism for synergistic effect of IRF4 and MITF on tyrosinase promoter].
    Song J; Liu X; Li J; Liu H; Peng Z; Chen H; Mei L; He C; Feng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):461-468. PubMed ID: 29886459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
    Peña-Chilet M; Blanquer-Maceiras M; Ibarrola-Villava M; Martinez-Cadenas C; Martin-Gonzalez M; Gomez-Fernandez C; Mayor M; Aviles JA; Lluch A; Ribas G
    BMC Cancer; 2013 Mar; 13():160. PubMed ID: 23537197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
    Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.
    Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
    Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
    Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
    Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ Attenuates 5-Hydroxytryptamine-Induced Melanogenesis in Primary Melanocyte.
    Zhou J; Ling J; Ping F
    Biol Pharm Bull; 2016; 39(7):1091-9. PubMed ID: 27374284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.
    Ward SV; Gibbs DC; Orlow I; Thomas NE; Kanetsky PA; Luo L; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Rosso S; Zanetti R; Dwyer T; Begg CB; Berwick M;
    Br J Dermatol; 2020 Jul; 183(1):163-165. PubMed ID: 31958143
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
    Gibbs DC; Ward SV; Orlow I; Cadby G; Kanetsky PA; Luo L; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Ollila DW; Begg CB; Berwick M; Thomas NE;
    Br J Dermatol; 2017 Nov; 177(5):e180-e182. PubMed ID: 28667740
    [No Abstract]   [Full Text] [Related]  

  • 16. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
    Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
    Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes.
    Zhang T; Choi J; Kovacs MA; Shi J; Xu M; ; ; Goldstein AM; Trower AJ; Bishop DT; Iles MM; Duffy DL; MacGregor S; Amundadottir LT; Law MH; Loftus SK; Pavan WJ; Brown KM
    Genome Res; 2018 Nov; 28(11):1621-1635. PubMed ID: 30333196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF4 rs12203592*T/T genotype is associated with nodular melanoma.
    Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    Melanoma Res; 2019 Aug; 29(4):445-446. PubMed ID: 31246726
    [No Abstract]   [Full Text] [Related]  

  • 19. Astaxanthin and withaferin A block paracrine cytokine interactions between UVB-exposed human keratinocytes and human melanocytes via the attenuation of endothelin-1 secretion and its downstream intracellular signaling.
    Niwano T; Terazawa S; Nakajima H; Wakabayashi Y; Imokawa G
    Cytokine; 2015 Jun; 73(2):184-97. PubMed ID: 25777483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
    Fang D; Setaluri V
    Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.